Lonza | GenomeWeb

Lonza

NEW YORK (GenomeWeb News) – Precision BioSciences said today that it is suing Lonza Group and a number of its affiliates for patent infringement.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Becton Dickinson announced the latest round of winners of its BD Biosciences Research Grant Program. Winners will receive $10,000 worth of research reagents for their projects.

Lonza now offers kits and services featuring Roche's MycoTool detection kits for final release testing of pharmaceutical products, upon validation. In the meantime, Lonza continues to develop its own pharma QC products, including mycoplasma detection assays, on BD's automated testing platform.

The MycoTool PCR-based test is the first commercial nucleic acid testing-based detection system for mycoplasma biosafety testing of approved biological products.

BD Diagnostics and Switzerland's Lonza have inked an agreement to develop and commercialize Lonza's microCompass molecular assays on the BD Max system for pharmaceutical quality-control testing.

Lonza's microCompass assays will facilitate rapid detection for total bioburden load, sterility testing, Mycoplasma, and other specific organisms, the two firms said.

BHB, founded in 2006, is betting that the new service offering will generate both new revenues and additional sales of its StellARray and XenoQ plate-based PCR kits.

Lonza is distributing Bar Harbor BioTechnology's new tools under an exclusive agreement.

Product Watch

Premium

Bar Harbor's XenoQ assays

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.